Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Apr-24 5:02 PM View:  | AP Pharma Inc. (HRTX) | 19-Apr-24 | Option Exercise | 3,874 | -- | -- | 5% 79.0K to 82.87K | |
| 21-Nov-23 12:19 PM View: | AP Pharma Inc. (HRTX) | 17-Nov-23 | Private Purchase | 25,000 | $1.09 | $27,250.00 | 46% 54.0K to 79.0K | |
| 20-Nov-23 10:07 AM View: | AP Pharma Inc. (HRTX) | 16-Nov-23 | Private Purchase | 50,000 | $0.94 | $46,995.00 | 1250% 4.0K to 54.0K | |
| 03-Apr-23 4:15 PM View: | Beyond Air, Inc. (XAIR) | 31-Mar-23 | Private Purchase | 5,000 | $6.67 | $33,350.00 | 51% 9.86K to 14.86K | |
| 20-Mar-23 4:05 PM View: | Beyond Air, Inc. (XAIR) | 17-Mar-23 | Private Purchase | 5,000 | $6.46 | $32,300.00 | 103% 4.86K to 9.86K | |
| 15-Nov-19 4:30 PM View: | Beyond Air, Inc. (XAIR) | 03-Jun-19 | Market Purchase | 4,855 | $5.15 | $25,003.20 | 100% 0 to 4.86K | (22%) |
| 03-Apr-15 11:53 AM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 51,714 | $173.00 | $8,946,520.00 | (100%) 51.71K to 0 | |
| 11-Mar-15 4:41 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 09-Mar-15 | Private Sale | 42,880 | $157.84 | $6,768,180.00 | (45%) 94.59K to 51.71K | |
| 09-Mar-15 4:56 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 06-Mar-15 | Private Sale | 20,000 | $157.96 | $3,159,200.00 | (17%) 114.59K to 94.59K | |
| 08-Jan-15 5:08 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Jan-15 | Payment of Exercise | 10,997 | $114.94 | $1,264,000.00 | (9%) 125.59K to 114.59K | (5%) |
| 14-Nov-14 10:00 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 12-Nov-14 | Option Exercise | 17,450 | $17.57 | $306,524.00 | 15% 119.22K to 136.67K | |
| 14-Nov-14 10:00 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 12-Nov-14 | Market Option Sale | 11,079 | $95.05 | $1,053,060.00 | (8%) 136.67K to 125.59K | (26%) |
| 26-Aug-14 6:58 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 22-Aug-14 | Grant | 19,809 | $158.30 | $3,135,760.00 | 20% 99.41K to 119.22K | (24%) |
| 03-Jul-14 9:46 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Jul-14 | Payment of Exercise | 1,971 | $123.35 | $243,123.00 | (2%) 101.38K to 99.41K | 3% |
| 21-Apr-14 9:29 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 17-Apr-14 | Grant | 19,809 | $100.66 | $1,993,970.00 | 24% 81.57K to 101.38K | 19% |
| 10-Jan-14 4:39 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 08-Jan-14 | Option Exercise | 8,000 | $17.53 | $140,240.00 | 10% 81.57K to 89.57K | |
| 10-Jan-14 4:39 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 08-Jan-14 | Market Option Sale (Planned) | 8,000 | $90.06 | $720,480.00 | (9%) 89.57K to 81.57K | (33%) |
| 06-Jan-14 9:27 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Jan-14 | Payment of Exercise | 8,851 | $89.94 | $796,059.00 | (10%) 90.42K to 81.57K | (34%) |
| 26-Jul-13 4:05 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 24-Jul-13 | Option Exercise | 12,000 | $17.53 | $210,360.00 | 13% 90.42K to 102.42K | |
| 26-Jul-13 4:05 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 24-Jul-13 | Market Option Sale (Planned) | 12,000 | $70.93 | $851,130.00 | (12%) 102.42K to 90.42K | (69%) |
| 03-Jul-13 4:59 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Jul-13 | Payment of Exercise | 4,835 | $66.15 | $319,835.00 | (5%) 95.26K to 90.42K | (82%) |
| 22-Apr-13 6:57 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 18-Apr-13 | Grant | 23,741 | $48.70 | $1,156,190.00 | 33% 71.52K to 95.26K | 147% |
| 12-Apr-13 5:05 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 10-Apr-13 | Option Exercise | 13,000 | $17.53 | $227,890.00 | 19% 67.19K to 80.19K | |
| 12-Apr-13 5:05 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 10-Apr-13 | Market Option Sale (Planned) | 8,673 | $49.37 | $428,186.00 | (11%) 80.19K to 71.52K | (143%) |
| 04-Jan-13 4:45 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Jan-13 | Payment of Exercise | 5,052 | $40.47 | $204,454.00 | (7%) 72.24K to 67.19K | (197%) |
| 05-Jul-12 4:45 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Jul-12 | Payment of Exercise | 4,107 | $54.44 | $223,585.00 | (5%) 76.35K to 72.24K | (121%) |
| 21-May-12 5:02 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 08-May-12 | Option Exercise | 10,000 | $17.53 | $175,300.00 | 13% 76.35K to 86.35K | |
| 21-May-12 5:02 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 08-May-12 | Market Option Sale (Planned) | 10,000 | $51.61 | $516,139.00 | (12%) 86.35K to 76.35K | (133%) |
| 27-Apr-12 4:42 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 25-Apr-12 | Grant | 20,713 | -- | -- | 37% 55.64K to 76.35K | |
| 15-Feb-12 5:30 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 13-Feb-12 | Option Exercise | 4,297 | $17.53 | $75,326.40 | 8% 55.64K to 59.93K | |
| 15-Feb-12 5:30 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 13-Feb-12 | Market Option Sale (Planned) | 4,297 | $50.00 | $214,850.00 | (7%) 59.93K to 55.64K | (140%) |
| 07-Feb-12 4:53 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 03-Feb-12 | Option Exercise | 259 | $17.53 | $4,540.27 | < 1% 55.64K to 55.9K | |
| 07-Feb-12 4:53 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 03-Feb-12 | Market Option Sale (Planned) | 259 | $50.00 | $12,950.00 | (< 1%) 55.9K to 55.64K | (140%) |
| 19-Jan-12 4:47 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 18-Jan-12 | Option Exercise | 125 | $17.53 | $2,191.25 | < 1% 55.64K to 55.76K | |
| 19-Jan-12 4:47 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 18-Jan-12 | Market Option Sale (Planned) | 125 | $50.00 | $6,250.00 | (< 1%) 55.76K to 55.64K | (140%) |
| 19-Jan-12 4:47 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 17-Jan-12 | Option Exercise | 1,119 | $17.53 | $19,616.10 | 2% 55.64K to 56.76K | |
| 19-Jan-12 4:47 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 17-Jan-12 | Market Option Sale (Planned) | 1,119 | $50.06 | $56,016.00 | (2%) 56.76K to 55.64K | (140%) |
| 05-Jan-12 4:16 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 03-Jan-12 | Payment of Exercise | 2,506 | $47.85 | $119,912.00 | (4%) 58.14K to 55.64K | (151%) |
| 11-Jul-11 4:59 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 07-Jul-11 | Market Sale (Planned) | 13,000 | $39.60 | $514,764.00 | (18%) 71.14K to 58.14K | (204%) |
| 06-Jul-11 6:18 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Jul-11 | Payment of Exercise | 9,212 | $39.83 | $366,914.00 | (11%) 80.36K to 71.14K | (202%) |
| 18-May-11 4:56 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 16-May-11 | Option Exercise | 20,000 | $17.53 | $350,600.00 | 25% 80.36K to 100.36K | |
| 18-May-11 4:56 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 16-May-11 | Market Option Sale | 20,000 | $40.35 | $806,986.00 | (20%) 100.36K to 80.36K | (198%) |
| 04-May-11 4:37 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 25-Apr-11 | Grant | 22,698 | -- | -- | 39% 57.66K to 80.36K | |
| 12-Nov-10 9:50 AM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 10-Nov-10 | Option Exercise | 10,000 | $17.53 | $175,300.00 | 17% 57.66K to 67.66K | |
| 12-Nov-10 9:50 AM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 10-Nov-10 | Market Option Sale (Planned) | 10,000 | $40.01 | $400,053.00 | (15%) 67.66K to 57.66K | (205%) |
| 16-Sep-10 4:28 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 15-Sep-10 | Market Sale (Planned) | 10,695 | $40.50 | $433,108.00 | (16%) 68.35K to 57.66K | (202%) |
| 21-Jul-10 10:50 AM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 19-Jul-10 | Grant | 15,055 | -- | -- | 28% 53.3K to 68.35K | |
| 06-Jul-10 4:24 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Jul-10 | Payment of Exercise | 7,586 | $39.03 | $296,082.00 | (12%) 60.88K to 53.3K | (213%) |
| 16-Apr-10 12:04 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 14-Apr-10 | Option Exercise | 10,000 | $17.53 | $175,300.00 | 16% 60.88K to 70.88K | |
| 16-Apr-10 12:04 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 14-Apr-10 | Market Option Sale (Planned) | 10,000 | $40.03 | $400,251.00 | (14%) 70.88K to 60.88K | (205%) |